These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17076955)

  • 1. Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.
    Lucioni A; Rapp DE; Gong EM; Fedunok P; Bales GT
    Can J Urol; 2006 Oct; 13(5):3291-5. PubMed ID: 17076955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P;
    Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children.
    Marte A; Borrelli M; Sabatino MD; Balzo BD; Prezioso M; Pintozzi L; Nino F; Parmeggiani P
    Eur J Pediatr Surg; 2010 May; 20(3):153-7. PubMed ID: 20112186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin type A in patients with overactive bladder].
    Krivoborodov GG; Vasil'ev AV; Shumilo DV; Ivanov AV; Tur EI
    Urologiia; 2010; (3):36-40. PubMed ID: 20734876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Jeffery S; Fynes M; Lee F; Wang K; Williams L; Morley R
    BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.
    Cohen BL; Barboglio P; Rodriguez D; Gousse AE
    Neurourol Urodyn; 2009; 28(3):205-8. PubMed ID: 19058190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
    Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].
    Bentaleb Y; Castel-Lacanal E; Sallusto F; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity.
    Manecksha RP; Cullen IM; Ahmad S; McNeill G; Flynn R; McDermott TE; Grainger R; Thornhill JA
    Eur Urol; 2012 May; 61(5):928-35. PubMed ID: 22078337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
    Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
    Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study.
    Giannantoni A; Costantini E; Di Stasi SM; Tascini MC; Bini V; Porena M
    Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.
    Kalsi V; Apostolidis A; Gonzales G; Elneil S; Dasgupta P; Fowler CJ
    Eur Urol; 2008 Jul; 54(1):181-7. PubMed ID: 18191323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
    White WM; Pickens RB; Doggweiler R; Klein FA
    J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.